| Dr. Dennis Jahovic & Associates,p.c. | |
|
2621 E 80th Ave, Merrillville, IN 46410-5761 | |
| (219) 942-6979 | |
| (219) 942-5125 |
| Full Name | Dr. Dennis Jahovic & Associates,p.c. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 2621 E 80th Ave, Merrillville, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063608628 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 18003033A (Indiana) | Primary |
| Provider Name | Dennis Jahovic |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1184731812 PECOS PAC ID: 8628237500 Enrollment ID: I20120313000329 |
News Archive
The use of contraceptives has increased among young women in Gothenburg, but not in areas that are socially vulnerable. This is the finding from a long-term study from Sahlgrenska Academy spanning four generations of young women.
Researchers from the US recently isolated two VHH nanobodies - 7A3 and 8A2 - from dromedary camels (Camelus dromedaries) using phage display. These nanobodies were found to have a high affinity for the spike RBD and broad neutralization abilities against SARS-CoV-2 and its variants.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
QLT Inc. today announced that it has initiated enrollment in a Phase Ib trial of QLT091001 in pediatric patients with Leber Congenital Amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle.
Life Technologies Corporation today announced the launch of its TaqMan Mutation Detection Assays - highly sensitive and novel molecular analysis research tools with the precision to detect a single mutant molecule hiding in a background of 1 million normal copies.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr. Dennis Jahovic & Associates,p.c. 2621 E 80th Ave, Merrillville, IN 46410-5761 Ph: (219) 942-6979 | Dr. Dennis Jahovic & Associates,p.c. 2621 E 80th Ave, Merrillville, IN 46410-5761 Ph: (219) 942-6979 |
News Archive
The use of contraceptives has increased among young women in Gothenburg, but not in areas that are socially vulnerable. This is the finding from a long-term study from Sahlgrenska Academy spanning four generations of young women.
Researchers from the US recently isolated two VHH nanobodies - 7A3 and 8A2 - from dromedary camels (Camelus dromedaries) using phage display. These nanobodies were found to have a high affinity for the spike RBD and broad neutralization abilities against SARS-CoV-2 and its variants.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
QLT Inc. today announced that it has initiated enrollment in a Phase Ib trial of QLT091001 in pediatric patients with Leber Congenital Amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle.
Life Technologies Corporation today announced the launch of its TaqMan Mutation Detection Assays - highly sensitive and novel molecular analysis research tools with the precision to detect a single mutant molecule hiding in a background of 1 million normal copies.
› Verified 7 days ago
Moses Eyecare Centers Optometrist Medicare: Medicare Enrolled Practice Location: 70 E 68th Pl, Merrillville, IN 46410 Phone: 219-736-2020 Fax: 219-769-3884 | |
Dr. Lisa Jennifer Saks-knestrict, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8510 Broadway, Merrillville, IN 46410 Phone: 219-736-2200 Fax: 219-736-2222 | |
Deen-gross Eye Centers Optometrist Medicare: Medicare Enrolled Practice Location: 303 W 89th Ave, Suite E4, Merrillville, IN 46410 Phone: 219-769-8989 Fax: 219-756-6389 | |
Dr. Calvin Butler Yates, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 141 E 61st Ave, Merrillville, IN 46410 Phone: 219-981-8890 | |
Sylvia Rebecca Mishoulam, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1310 E 79th Ave, Merrillville, IN 46410 Phone: 219-641-6406 | |
Jamie Taffora, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 303 W 89th Ave, Merrillville, IN 46410 Phone: 219-769-8989 Fax: 219-756-0560 |